Activating Transcription Factor 2 (ATF2) (N-Term) Peptide
Quick Overview for Activating Transcription Factor 2 (ATF2) (N-Term) Peptide (ABIN973547)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- TPTPTRFLKN CEEVGLFNEL ASPFENEFKK ASEDDIKKMP LDLSPLATPI
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Atf2 Antibody,. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ATF2 (Activating Transcription Factor 2 (ATF2))
-
Background
-
Atf2 is a transcriptional activator, probably constitutive, which binds to the cAMP-responsive element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in many viral and cellular promoters. Interaction with JUN redirects JUN to bind to CRES preferentially over the 12-O-tetradecanoylphorbol-13-acetate response elements (TRES) as part of an ATF2/JUN complex.
Alias Symbols: -
Protein Interaction Partner: CEBPA,CEBPB
Protein Size: 487 -
Molecular Weight
- 52 kDa
-
Gene ID
- 81647
-
NCBI Accession
- NM_031018, NP_112280
-
UniProt
- Q00969
Target
-